Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-90,184
Closed -$1.99M – 204
2019
Q2
$1.99M Sell
90,184
-8,210
-8% -$190K 0.26% 117
2019
Q1
$2.33M Sell
98,394
-3,158
-3% -$73.8K 0.31% 110
2018
Q4
$2.26M Sell
101,552
-12,074
-11% -$290K 0.32% 113
2018
Q3
$2.96M Sell
113,626
-2,812
-2% -$78K 0.32% 116
2018
Q2
$3.14M Sell
116,438
-1,405
-1% -$37.2K 0.35% 111
2018
Q1
$3.05M Sell
117,843
-16,310
-12% -$446K 0.35% 113
2017
Q4
$3.69M Buy
+134,153
New +$3.56M 0.37% 109

Other funds holding TBI

Leuthold Group's TBI Position: Q3 2019 in Review

Leuthold Group sold out of Trueblue (TBI) in Q3 2019, closing a stake of 90,184 shares — an estimated $1.99M sold.

Leuthold Group first reported a position in TBI in Q4 2017 and held it in 7 quarters. The position peaked at $3.69M in Q4 2017. 172 funds tracked by Wall St. Rank hold TBI as of Q3 2019.

  • Leuthold Group reported no remaining Trueblue position as of Q3 2019 after selling out during the quarter.
  • Leuthold Group sold 90,184 Trueblue shares in Q3 2019, an estimated $1.99M.
  • Leuthold Group first reported a position in Trueblue in Q4 2017 and held it in 7 quarters.
  • Leuthold Group's Trueblue position peaked at $3.69M in Q4 2017.
  • 172 funds tracked by Wall St. Rank held Trueblue as of Q3 2019.

Based on Leuthold Group's 13F filing for Q3 2019, filed 14 Nov 2019.